BioSource International, Inc. to Announce Fourth Quarter and Fiscal Year 2003 Financial Results and 2004 Outlook on February 26, 2004.Business Editors CAMARILLO, Calif.--(BUSINESS WIRE)--Jan. 29, 2004 BioSource International, Inc. (Nasdaq:BIOI) will announce its fourth quarter and fiscal year 2003 financial results and its 2004 outlook on February 26, 2004. The Company will also hold its quarterly conference call to discuss the 2003 results and 2004 outlook on Thursday, February 26, 2004, at 1:00 p.m. Eastern Time (10 a.m. Pacific Time). This call is being webcast by CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network and can be accessed at BioSource's web site at www.biosource.com. Interested parties may participate by calling 800-299-7635. The code number is 24199362. A Q&A session will be available toward the end of the conference call. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com). About BioSource BioSource International, Inc. is a broad-based life sciences company focused on providing integrated solutions in the areas of functional genomics Noun 1. functional genomics - the branch of genomics that determines the biological function of the genes and their products genomics - the branch of genetics that studies organisms in terms of their genomes (their full DNA sequences) , proteomics pro·te·o·mics n. The analysis of the expression, localization, functions, and interactions of the proteins produced by the genes of an organism. , and drug discovery through the development, manufacturing, marketing and distribution of unique biologically active reagent reagent /re·a·gent/ (re-a´jent) a substance used to produce a chemical reaction so as to detect, measure, produce, etc., other substances. re·a·gent n. systems which facilitate, enable and accelerate pharmaceutical development and biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion